Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-07-31

Clinical Trial Update: Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a high viscosity dietary fibre within a medically supervised weight management program for obesity was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Canadian Center for Functional Medicine | Conditions: Obesity | Phase 3 | Status: WITHDRAWN